The global medical imaging market is undergoing a structural transition from fragmented, analog operational models to centralised, API-driven infrastructure layers. Scan.com’s $220 million capital raise marks a critical inflection point in this market shift, establishing the capital foundation required to consolidate the fragmented United States diagnostic ecosystem. By pairing growth equity with non dilutive acquisition debt facilities, the organisation is accelerating the d

The United Kingdom occupational health (OH) market is undergoing an unprecedented structural consolidation driven by private equity capital deployment, corporate carve outs, and buy and build strategies. Valued between £1.5 billion and £2.0 billion and expanding at an annual growth rate of 6% to 9%, the sector sits at the intersection of acute macroeconomic pressures, severe healthcare labour constraints and evolving statutory obligations for employers. Over the past 24 month

The global biopharmaceutical and medical technology (MedTech) sectors have entered a period of structural dealmaking transformation. Historically, large scale mergers and acquisitions (M&A) served as the primary instrument for multinational pharmaceutical corporations (MNCs) seeking to replenish depleted R&D pipelines, acquire proprietary drug discovery platforms and secure top-line growth. However, the economic rationale underpinning transformative M&A has been reshaped by a